Loperamide, the over-the-counter antidiarrheal medication, is in the news. A recent paper in the Annals of Emergency Medicine documents two loperamide-induced deaths, [1] and loperamide-associated ...
The US Food and Drug Administration (FDA) announced new action today to combat the growing problem of abuse and misuse of the over-the-counter (OTC), opioid-based antidiarrheal medication loperamide ...
As for treating Torsade de Pointes, a review of cases related to loperamide abuse showed that patients may not respond well to magnesium sulfate, a standard therapy. In these patients, White noted, ...
When the emergency team arrived, it was already too late. The 24-year-old man, who had a history of opioid addiction, was not breathing and lacked a pulse. His case report, recently published in the ...
NEW BRUNSWICK, N.J. (WPVI) -- Rutgers University researchers say they have uncovered a new threat in the opioid crisis - a rise in overdoses from the abuse of an over-the-counter diarrhea medication.
When the emergency team arrived, it was already too late. The 24-year-old man, who had a history of opioid addiction, was not breathing and lacked a pulse. His case report, recently published in the ...
pill bottles shelf An increase in loperamide (Imodium) abuse as an opioid substitute has been seen among patients trying to self-treat their opioid addiction, according to a case studies report ...
The FDA doesn't trust you to treat your own runs. Over-the-counter medicine frees Americans to treat minor health issues without first consulting an expert. For no ailment is this freedom more of a ...
The over-the-counter anti-diarrhea medication Imodium, or its key ingredient loperamide, is increasingly being abused by people attempting to self-treat their opioid addiction, with sometime fatal ...
As part of its efforts to combat the opioid epidemic, the U.S. Food & Drug Administration is asking manufacturers of over-the-counter anti-diarrhea treatments to change the way they package their ...
Loperamide, a non-prescription antidiarrhoeal with μ‐opioid receptor agonist properties, has long been considered safe when used at therapeutic doses. However, there is increasing evidence that its ...
As part of the fight against the nation’s opioid epidemic, the US Food and Drug Administration said Tuesday, one common antidiarrheal drug should be given new packaging. The agency is working with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results